Unless otherwise noted, all chemicals were obtained from commercial sources and used without further purification. Amino acid derivatives, coupling reagents, and resins were purchased from Novabiochem (San Diego, CA) and AnaSpec (San Jose, CA). pTXB1 vector and chitin beads were purchased from New England Biolabs (Ipswich, MA). Flash chromatography was performed with SiliCycle silica gel 60 Å (40-63 µm). All reactions were carried out under argon using oven-dried glassware. 
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the small-molecule modified peptides was performed using Phenomenex Luna 5 µm C 18 100 Å (10.00 × 250 mm) column with a flow rate of 5 mL/min. Analysis of small-molecule modified proteins was performed using GRACE Vydac 218TP54 5 µm C 18 column (4.6×250 mm) with a flow rate of 1.5 mL/min and UV detection set at 220 and 254 nm.
Gel Analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of proteins was performed on an XCell SureLock Mini-Cell apparatus using NuPAGE 4-12% Bis-Tris gels (Invitrogen).
BenchMark Prestained Protein Ladder was applied to at least one lane of each gel for estimation of apparent molecular weights. Visualization of protein bands was accomplished by staining with SimplyBlue SafeStain solutions (Invitrogen). For fluorescent gel imaging, the gel was illuminated from one side using a hand-held 365 m UV lamp and the fluorescence image was recorded using a digit camera.
Gel Filtration. Before LC-MS and HPLC analysis, gel filtration chromatography (Sephadex G-25, GE Healthcare) was performed to remove salts and small molecules from protein samples with ddH 2 O as the elution buffer. Size exclusion chromatography (Superdex 75, Amersham Biosciences) was performed to isolate the tetrazole-modified EGFP from the ligation mixture with an elution buffer of 20 mM Tris, 500 mM NaCl, 1 mM EDTA, pH 7.5.
Synthesis of Tetrazole Tails:
2-(4-Methoxy-phenyl)-2H-tetrazole-5-carboxylic acid: To 1.6 mL of ethyl glyoxialate in toluene was added 130 mL ethanol solution of sulfonyl hydrazide (1.38 g, 8.0 mmol). The resulting mixture was stirred for 1 hr at room temperature in an open flask before being pored over 100 g of ice. A white precipitate (sulfonyl hydrazone) was generated, which was collected by filtration. The filtrate was subsequently dissolved in 50 mL pyridine to derive solution A. Separately, to a 7.2 mmol solution of 4-methoxy-aniline in a 3:1 mixture of ethanol and water (20 mL cooled to -5 °C) was added 3.0 mL of concentrated HCl. To the resulting acidic aniline solution, 4 mL solution of sodium nitrite (0.690 g, 10 mmol) was added dropwise to generate the phenyl diazonium salt (solution B). Solution A was cooled to -20 °C and solution B (kept at -5 °C) was added dropwise to solution A over a period of 30 minutes. Following addition, the reaction mixture was allowed to warm up to room temperature over 60 minutes and subsequently extracted with ethyl acetate three times. The organic layer was then washed with 0.1 N HCl, dried over sodium sulfate, and concentrated. The crude mixture was purified via a silica gel chromatography using a stepwise gradient of ethyl acetate/hexane to afford 2-(4-methoxy-phenyl)-2H-tetrazole-5-ethyl ester as a light yellow-brown powder. Following purification, sodium hydroxide (7.5 mmol; 0.6 g dissolved in 2 mL of 6, 160.4, 159.1, 129.7, 121.8, 115.3, 115.0, 55.8, 55.6; HRMS (EI) anhydrous THF) via a syringe pump at a rate of 50 µL/min. Following addition the reaction was allowed to stir overnight. The crude reaction mixture was concentrated and then re-dissolved in 100 mL CH 2 Cl 2 .
The solution was washed 3 times with 10% KHSO 4 , and the organic layer was separated before evaporation under the reduced pressure. The residue was applied to a silica gel column using 1:20 MeOH/CH 2 Cl 2 as an eluent to afford the titled compound as a slight yellow foam (0.781 g, 67%): 9, 160.7, 159.9, 156.1, 143.8, 140.7, 129.3, 127.6, 127.0, 125.2, 122.0, 120.1, 115.1,68.1, 55.7, 53.6, 46.6, 30.4, 28.4, 23 
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reactions were allowed to proceed for 1 hr. For coupling of natural amino acids, three equiv of amino acids, three equiv of HBTU/HOBt, and six equiv of DIEA in DMF were used, and the reactions were allowed to proceed for 45 min. The Fmoc deprotection was accomplished by treating the resin-bound peptides with 20% piperidine/DMF (2×, 10 min each). The peptides were cleaved from the Wang resin by treating the resin with 1 mL cleavage cocktail (94% TFA, 2.5% water, 2.5% ethanedithiol, 1% triisopropylsilane) for 1 hr. The cleavage solutions were filtered into cold ether and the precipitated crude peptides were found to be greater than 90% pure by analytical HPLC and LC-MS. Then a solution of hexadecan-1-amine (965.8 mg, 3.80 mmol) in 20 mL CH 2 Cl 2 was added dropwise.
After 12 h, the solution was diluted with CH 2 Cl 2 and filtrated; 20 mL water was added and washed. The mixture was washed with saturated NaHCO 3 , brine, dried over Na 2 SO 4 . The residue was purified via silica gel column to obtain the title compound as a glossy white solid (820.0 mg, 61.0% yield): The solution was acidified with 1.0 M HCl and the precipitate was filtrated and dried in vacuo. The crude product was recrystallized in THF to give the desired product as a white solid (520 mg, 94% 
Construction of pTXB1-EGFP plasmid:
The EGFP fragment carrying Nde I and Sap I restriction site at the 5'-and 3'-end, respectively, was amplified through a PCR reaction using pEGFP-C1 as the template and the following two primers: 5'-GGTGGTCATATGGTGAGCAAGGGCGAGG-3' and 5'-GGTGGTTGCTCTTCCGCACTTGTACAGCTCGTCC-3' (restriction sites underlined). After gel purification, the EGFP fragment was digested with Nde I and Sap I in the NEBuffer 4 at 37°C for 2 hr.
The digested EGFP fragment was purified by 1% agarose gel and incubated with the pTXB1 vector predigested with Nde I/Sap I and T4 DNA ligase at 14°C overnight. Afterwards, 1 µL of the ligation mixture was used to transform MaxEfficiency DH5α competent cells (Invitrogen), and the transformants were selected on an LB agar plate containing 50 µg/mL ampicillin.
Preparation of EGFP-Tet 3 and 4:
pTXB1-EGFP plasmid was transformed into the Rosetta competent cells (Novagen) using the heat-shock method and plated onto LB agar plate containing 50 µg/mL ampicillin. The single colony picked from the plate was allowed to grow in 20 mL LB medium supplemented with 50 µg/mL ampicillin at 37 ºC. The overnight culture was diluted into 1000 mL fresh LB medium containing 50 µg/mL ampicillin and allowed to grow at 30 ºC until OD600 reached 0.6.
Induction of EGFP was initiated by adding 0.3 mM IPTG and the culture was allowed to grow overnight.
The cells were harvested and the EGFP-intein-CBD fusion protein in the supernatant was captured onto a freshly prepared affinity column loaded with 1.2 mL chitin beads followed by 5× washing with 10 mL each of wash buffer (20 mM Tris, 500 mM NaCl, 1 mM EDTA, pH 7.5). The beads were treated with 2 mL of cleavage buffer (wash buffer supplemented with 3 mM Tet 1 or 2 and 50 mM MESA) for 48 hr at 4 ºC. The filtrate was applied to Amicon Ultra-4 10K device (Millipore) to remove excess amount of small molecules and salts, then purified by FPLC (Mono Q 5/50, GE Healthcare). The fractions were examined by SDS-PAGE, and the pure fractions were pooled to give EGFP-Tet 3 and EGFP-Tet 4, respectively. ESI-MS calcd for EGFP-Tet 3⋅ ⋅ ⋅ ⋅MESA 27536.9 Da, found 27547.7 ± 8.7 Da. 
